Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery disease.
Gries JJ, Lazarus JV, Brennan PN, Siddiqui MS, Targher G, Lang CC, Virani SS, Lavie CJ, Isaacs S, Arab JP, Cusi K, Krittanawong C. Gries JJ, et al. Among authors: cusi k. Lancet Gastroenterol Hepatol. 2025 Jan;10(1):82-94. doi: 10.1016/S2468-1253(24)00310-8. Lancet Gastroenterol Hepatol. 2025. PMID: 39674228 Review.
Summary of Revisions: Standards of Care in Diabetes-2025.
American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. Diabetes Care. 2025 Jan 1;48(1 Suppl 1):S6-S13. doi: 10.2337/dc25-SREV. Diabetes Care. 2025. PMID: 39651984 Review. No abstract available.
Introduction and Methodology: Standards of Care in Diabetes-2025.
American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. Diabetes Care. 2025 Jan 1;48(1 Suppl 1):S1-S5. doi: 10.2337/dc25-SINT. Diabetes Care. 2025. PMID: 39651982 No abstract available.
Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Noureddin M, Truong E, Mayo R, Martínez-Arranz I, Mincholé I, Banales JM, Arrese M, Cusi K, Arias-Loste MT, Bruha R, Romero-Gómez M, Iruzubieta P, Aller R, Ampuero J, Calleja JL, Ibañez-Samaniego L, Aspichueta P, Marín-Duce A, Kushner T, Ortiz P, Harrison SA, Anstee QM, Crespo J, Mato JM, Sanyal AJ. Noureddin M, et al. Among authors: cusi k. Hepatology. 2025 Jan 1;81(1):E12-E16. doi: 10.1097/HEP.0000000000001061. Epub 2024 Sep 26. Hepatology. 2025. PMID: 39325967 No abstract available.
Detecting altered hepatic lipid oxidation by MRI in an animal model of MASLD.
McLeod M, Chang MC, Rushin A, Ragavan M, Mahar R, Sharma G, Badar A, Giacalone A, Glanz ME, Malut VR, Graham D, Sunny NE, Bankson JA, Cusi K, Merritt ME. McLeod M, et al. Among authors: cusi k. Cell Rep Med. 2024 Sep 17;5(9):101714. doi: 10.1016/j.xcrm.2024.101714. Epub 2024 Sep 5. Cell Rep Med. 2024. PMID: 39241774 Free PMC article.
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease.
Younossi ZM, AlQahtani SA, Funuyet-Salas J, Romero-Gómez M, Yilmaz Y, Keklikkiran C, Alswat K, Yu ML, Liu CJ, Fan JG, Zheng MH, Burra P, Francque SM, Castera L, Schattenberg JM, Newsome PN, Allen AM, El-Kassas M, Treeprasertsuk S, Hameed S, Wai-Sun Wong V, Zelber-Sagi S, Takahashi H, Kawaguchi T, Castellanos Fernández MI, Duseja A, Arrese M, Rinella M, Singal AK, Gordon SC, Fuchs M, Eskridge W, Alkhouri N, Cusi K, Loomba R, Ranagan J, Kautz A, Ong JP, Kugelmas M, Eguchi Y, Diago M, Gerber L, Lam B, Fornaresio L, Nader F, Spearman CW, Roberts SK, Chan WK, Silva M, Racila A, Golabi P, Ananchuensook P, Henry L, Stepanova M, Carrieri P, Lazarus JV; Global NASH Council. Younossi ZM, et al. Among authors: cusi k. JHEP Rep. 2024 Mar 12;6(7):101066. doi: 10.1016/j.jhepr.2024.101066. eCollection 2024 Jul. JHEP Rep. 2024. PMID: 39022387 Free PMC article.
262 results